USP posts the status of Revisions, Deferrals, Cancellations, and Commentary for each edition of USP–NF.
- Revisions are approved standards that will appear in the publication.
- Deferrals are items that have been proposed in Pharmacopeial Forum (PF) but are not yet approved by an Expert Committee.
- Cancellations are items that have been proposed in PF but have been canceled. Canceled items may be re-proposed in a future PF.
- Commentary is a summary of comments received and the appropriate Expert Committee's responses in cases when proposals advance to official status without being re-published in PF.
- The Index is a copy of the combined Index for a given Book or Supplement. The Index is posted for informational use only and should not be used for interpretive purposes.
Revisions, Deferrals, and Cancellations generally are posted in advance of posting of the online USP–NF or Supplement. Commentary and Index are posted the same day the online USP–NF, Supplement, or other official text is released.
Now Available: 2020 Cumulative List of USP–NF Revisions (updated 18–Dec–2020)
The Cumulative List of USP–NF Revisions provides updated information on all items approved, deferred, or cancelled during the 2020-2025 Cycle.
Interim Revision Announcements
As of First Supplement to USP 43–NF 38, IRAs are no longer associated with a print publication and are immediately available on USP–NF Online.
IRAs published in PF 46(5)
- Proposed for comment:
- Desmopressin Acetate
- Ribose
- Triamcinolone Acetate Nasal Spray
IRAs published in PF 46(4)
- Filgrastim
- No comments were received when this revision was published in PF
IRAs published in PF 46(3)
- Deferrals: General Notices
- Cancellations: None
- Commentary for IRAs posted on September 25, 2020 (updated 14–Oct–2020)
- Cetyl Alcohol
- Stearyl Alcohol
- Telmisartan and Amlodipine Tablets
IRAs published in PF 46(2)
- Deferrals: Paroxetine Hydrochloride
- Cancellations: None
- Commentary for IRAs posted on July 31, 2020
- <7> Labeling
- Temozolomide
- Temozolomide Capsules
- Temozolomide for Injection
- Travoprost Ophthalmic Solution
IRAs published in PF 46(1)
No new IRAs were published for comment in PF 46(1)
Pharmacopeial Forum 45, Issues 1-6
USP–NF 2021, Issue 2
- Deferrals (posted 28–Dec–2020)
- Cancellations (posted 28–Dec–2020)
- Revisions (posted 28–Dec–2020)
USP–NF 2021, Issue 1
- Deferrals (posted 25–Sep–2020)
- Cancellations (posted 25–Sep–2020)
- Revisions (posted 25–Sep–2020)
- Commentary (posted 02–Nov–2020)
USP 43–NF 38
Supplement 2
- Revisions (posted 24–Apr–2020)
- Deferrals (posted 24–Apr–2020)
- Cancellations (posted 24–Apr–2020)
- Commentary (posted 01–Jun–2020)
Supplement 1
Due to the extended comment period for Pharmacopeial Forum 45(1), it will be included in the publication for Supplement 1 instead of that for USP–NF.
- Revisions (posted 26–Dec–2019)
- Deferrals (posted 26–Dec–2019)
- Cancellations (posted 26–Dec–2019)
- Commentary (posted 03–Feb–2020; revised 05–Feb–2020)
Book
- Revisions (posted 26–Jul–2019)
- Deferrals (posted 26–Jul–2019)
- Cancellations (posted 26–Jul–2019)
- Commentary (posted 01–Nov–2019)
- Index (posted 01–Nov–2019)
IRAs published in 44(6)
- There were no IRAs published for comment in 44(6)